Abetimus sodium
阿贝莫司钠
Report date: 2022/07/04 19:38:02
NME
Base Information
Drug NameAbetimus sodium
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[36]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesLa Jolla Pharmaceutical Company
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesLa Jolla Pharmaceutical CompanyBaxter Pharmaceuticals Solutions Llc
Active IndicationsN/A
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksKEGG